STAU1 promotes adipogenesis by regulating the alternative splicing of Pparγ2 mRNA.
暂无分享,去创建一个
Shuo Jiang | Xiaodi Liang | Jialei Sun | Siyuan Chen | Xuanyu Meng | H. Gu | Dihui Liu | Zhe Chen | Jialei Sun
[1] Q. Xiong,et al. CHD7 regulates bone-fat balance by suppressing PPAR-γ signaling , 2022, Nature Communications.
[2] T. Adrian,et al. α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study , 2022, PPAR research.
[3] A. Cypess. Reassessing Human Adipose Tissue. , 2022, The New England journal of medicine.
[4] P. Ghosh,et al. Parsing the Role of PPARs in Macrophage Processes , 2021, Frontiers in Immunology.
[5] Shekoufeh Almasi,et al. The multifunctional RNA-binding protein Staufen1: an emerging regulator of oncogenesis through its various roles in key cellular events , 2021, Cellular and Molecular Life Sciences.
[6] Hui-Ying Lim,et al. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice , 2021, Molecular metabolism.
[7] Yaqun Guan,et al. Staufen1 unwinds the secondary structure and facilitates the translation of fatty acid binding protein 4 mRNA during adipogenesis , 2021, Adipocyte.
[8] S. Pulst,et al. Staufen1 in Human Neurodegeneration , 2021, Annals of neurology.
[9] Wei Xie,et al. Homotypic clustering of L1 and B1/Alu repeats compartmentalizes the 3D genome , 2021, Cell Research.
[10] A. R. Silva,et al. PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases , 2021, International journal of molecular sciences.
[11] K. Clément,et al. Metabolism and Metabolic Disorders and the Microbiome: The intestinal microbiota associated with obesity, lipid metabolism and metabolic health: pathophysiology and therapeutic strategies. , 2020, Gastroenterology.
[12] X. Wen,et al. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis. , 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[13] Yi Zhong,et al. STAU1 selectively regulates the expression of inflammatory and immune response genes and alternative splicing of the nerve growth factor receptor signaling pathway , 2020, Oncology reports.
[14] W. Wang,et al. 3′READS + RIP defines differential Staufen1 binding to alternative 3′UTR isoforms and reveals structures and sequence motifs influencing binding and polysome association , 2020, RNA.
[15] Š. Vaňáčová,et al. Staufen1 reads out structure and sequence features in ARF1 dsRNA for target recognition , 2019, Nucleic acids research.
[16] H. Urlaub,et al. Insights into the assembly and architecture of a Staufen-mediated mRNA decay (SMD)-competent mRNP , 2019, Nature Communications.
[17] Y. Shav-Tal,et al. The dynamic lifecycle of mRNA in the nucleus. , 2019, Current opinion in cell biology.
[18] P. Scherer,et al. Adipogenesis and metabolic health , 2019, Nature Reviews Molecular Cell Biology.
[19] J. Côté,et al. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier , 2016, PLoS genetics.
[20] Lan Lin,et al. rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.
[21] Q. Tang,et al. Transcriptional Regulation of Adipocyte Differentiation: A Central Role for CCAAT/Enhancer-binding Protein (C/EBP) β* , 2014, The Journal of Biological Chemistry.
[22] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[23] L. Maquat,et al. mRNA–mRNA duplexes that auto-elicit Staufen1-mediated mRNA decay , 2013, Nature Structural &Molecular Biology.
[24] Yoon Ki Kim,et al. Staufen1-mediated mRNA decay functions in adipogenesis. , 2012, Molecular cell.
[25] J. Côté,et al. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing , 2012, The Journal of cell biology.
[26] Shingo Kajimura,et al. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. , 2012, Cell metabolism.
[27] Chuan-Yun Li,et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases , 2011, Nucleic Acids Res..
[28] Yan Zhou,et al. Evolution of peroxisome proliferator-activated receptor gamma alternative splicing. , 2010, Frontiers in bioscience.
[29] L. Maquat,et al. Staufen1 regulates diverse classes of mammalian transcripts , 2007, The EMBO journal.
[30] W. Wahli,et al. Fat poetry: a kingdom for PPARγ , 2007, Cell Research.
[31] A. Ciccodicola,et al. A Novel Peroxisome Proliferator-activated Receptor γ Isoform with Dominant Negative Activity Generated by Alternative Splicing* , 2005, Journal of Biological Chemistry.
[32] X. Chen,et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.